Xiaoyang Sun
Xuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma.
Journal: Drug design, development and therapy
Published: May 22, 2020
The selective HDAC6 inhibitor Nexturastat A induces apoptosis, overcomes drug resistance and inhibits tumor growth in multiple myeloma.
Journal: Bioscience reports
Published: October 23, 2018
Identification of a novel c-Myc inhibitor with antitumor effects on multiple myeloma cells.
Journal: Bioscience reports
Published: June 26, 2018
Anti-Proliferative Activity of HPOB against Multiple Myeloma Cells via p21 Transcriptional Activation.
Journal: Molecules (Basel, Switzerland)
Published: April 05, 2018
Lithium chloride inhibits cell survival, overcomes drug resistance, and triggers apoptosis in multiple myeloma via activation of the Wnt/β-catenin pathway.
Journal: American journal of translational research
Published: December 22, 2017
Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21.
Journal: Experimental hematology
Published: October 10, 2017
Histone deacetylase inhibitor NaBut suppresses cell proliferation and induces apoptosis by targeting p21 in multiple myeloma.
Journal: American journal of translational research
Published: May 24, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026